Urinary proteomic biomarkers in coronary artery disease

Molecular and Cellular Proteomics

Volumn 7, Issue 2, 2008, Pages 290-298

  Zimmerli, Lukas U ^a,b   Schiffer, Eric ^c   Zürbig, Petra ^c   Good, David M ^d   Kellmann, Markus ^e   Mouls, Laetitia ^f   Pitt, Andrew R ^f   Coon, Joshua J ^d   Schmieder, Roland E ^g   Peter, Karlheinz H ^h   Mischak, Harald ^c   Kolch, Walter ^f,i   Delles, Christian ^a   Dominiczak, Anna F ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c MOSAIQUES DIAGNOSTICS GMBH   (Germany)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^e THERMO FISHER SCIENTIFIC   (Germany)

^f UNIVERSITY OF GLASGOW   (United Kingdom)

^g UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^h BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

ⁱ BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; POLYPEPTIDE;

ADULT; AMINO ACID SEQUENCE; ARTICLE; CAPILLARY ELECTROPHORESIS; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC VALUE; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEOMICS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; URINALYSIS; URINARY PROTEOMICS;

AMINO ACID SEQUENCE; BIOLOGICAL MARKERS; BODY MASS INDEX; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEOME; ROC CURVE;

EID: 39749160938     PISSN: 15359476     EISSN: None     Source Type: Journal    
DOI: 10.1074/mcp.M700394-MCP200     Document Type: Article

References (53)

1. McGregor, E., and Dunn, M. J. (2006) Proteomics of the heart: unraveling disease. Circ. Res. 98, 309-321
2. Fazzini, P. F., Prati, P. L., Rovelli, F., Antoniucci, D., Menghini, F., Seccareccia, F., and Menotti, A. (1993) Epidemiology of silent myocardial ischemia in asymptomatic middle-aged men (the Eccis Project). Am. J. Cardiol. 72, 1383-1388
3. Scognamiglio, R., Negut, C., Ramondo, A., Tiengo, A., and Avogaro, A. (2006) Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus. J. Am. Coll. Cardiol. 47, 65-71
4. Hanash, S. (2003) Disease proteomics. Nature 422, 226-232
5. Kolch, W., Neususs, C., Pelzing, M., and Mischak, H. (2005) Capillary electrophoresis-mass spectrometry as a powerful tool in clinical diagnosis and biomarker discovery. Mass Spectrom. Rev. 24, 959-977
6. Hewitt, S. M., Dear, J., and Star, R. A. (2004) Discovery of protein biomarkers for renal diseases. J. Am. Soc. Nephrol. 15, 1677-1689
7. O'Riordan, E., and Goligorsky, M. S. (2005) Emerging studies of the urinary proteome: the end of the beginning? Curr. Opin. Nephrol. Hypertens. 14, 579-585
8. D'Amico, G., and Bazzi, C. (2003) Pathophysiology of proteinuria. Kidney Int. 63, 809-825
9. National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am. J. Kidney Dis. 39, S1-S266
10. Cohn, J. N., Finkelstein, S., McVeigh, G., Morgan, D., LeMay, L., Robinson, J., and Mock, J. (1995) Noninvasive pulse wave analysis for the early detection of vascular disease. Hypertension 26, 503-508
11. Pauca, A. L., O'Rourke, M. F., and Kon, N. D. (2001) Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension 38, 932-937
12. Mischak, H., Apweiler, R., Banks, R., Conaway, M., Coon, J., Dominiczak, A., Ehrich, J., Fliser, D., Girolami, M., Hermjakob, H., Hochstrasser, D., Jankowski, J., Julian, B. A., Kolch, W., Massy, Z. A., Neusuess, C., Novak, J., Peter, K., Rossing, K., Schanstra, J., Semmes, O. J., Theodorescu, D., Thongboonkerd, V., Weissinger, E. M., Van Eyk, J. E., and Yamamoto, T. (2007) Clinical proteomics: a need to define the field and to begin to set adequate standards. Proteomics Clin. Appl. 1, 148-156
13. Taylor, C. F., Paton, N. W., Lilley, K. S., Binz, P. A., Julian, R. K., Jr., Jones, A. R., Zhu, W., Apweiler, R., Aebersold, R., Deutsch, E. W., Dunn, M. J., Heck, A. J., Leitner, A., Macht, M., Mann, M., Martens, L, Neubert, T. A., Patterson, S. D., Ping, P, Seymour, S. L., Souda, P., Tsugita, A., Vandekerckhove, J., Vondriska, T. M., Whitelegge, J. P., Wilkins, M. R., Xenarios, I., Yates, J. R., III, and Hermjakob, H. (2007) The minimum information about a proteomics experiment (MIAPE). Nat. Biotechnol. 25, 887-893
14. Singh, S. J., Morgan, M. D., Hardman, A. E., Rowe, C., and Bardsley, P. A. (1994) Comparison of oxygen uptake during a conventional treadmill test and the shuttle walking test in chronic airflow limitation. Eur Respir. J. 7, 2016-2020
15. Theodorescu, D., Wittke, S., Ross, M. M., Walden, M., Conaway, M., Just, I., Mischak, H., and Frierson, H. F. (2006) Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis. Lancet Oncol. 7, 230-240
16. Weissinger, E. M., Wittke, S., Kaiser, T., Haller, H., Bartel, S., Krebs, R., Golovko, I., Rupprecht, H. D., Haubitz, M., Hecker, H., Mischak, H., and Fliser, D. (2004) Proteomic patterns established with capillary electrophoresis and mass spectrometry for diagnostic purposes. Kidney Int 65, 2426-2434
17. Wittke, S., Mischak, H., Walden, M., Kolch, W., Radler, T., and Wiedemann, K. (2005) Discovery of biomarkers in human urine and cerebrospinal fluid by capillary electrophoresis coupled to mass spectrometry: towards new diagnostic and therapeutic approaches. Electrophoresis 26, 1476-1487
18. Wittke, S., Fliser, D., Haubitz, M., Bartel, S., Krebs, R., Hausadel, F., Hillmann, M., Golovko, I., Koester, P., Haller, H., Kaiser, T., Mischak, H., and Weissinger, E. M. (2003) Determination of peptides and proteins in human urine with capillary electrophoresis-mass spectrometry, a suitable tool for the establishment of new diagnostic markers. J. Chromatogr. A 1013, 173-181
19. Theodorescu, D., Fliser, D., Wittke, S., Mischak, H., Krebs, R., Walden, M., Ross, M., Eltze, E., Bettendorf, O., Wulfing, C., and Semjonow, A. (2005) Pilot study of capillary electrophoresis coupled to mass spectrometry as a tool to define potential prostate cancer biomarkers in urine. Electrophoresis 26, 2797-2808
20. DeLeo, J. (1993) Receiver operating characteristics laboratory (ROCLAB): software for developing decision strategies that account for uncertainty, in Second international Symposium on Uncertainty Modeling and Analysis: Proceedings April 25-28, 1993 University of Maryland College Park, Maryland (Isuma '93) (Institute of Electrical and Electronics Engineers, ed) pp. 318-325, IEEE Computer Society, Washington, D. C.
21. Coon, J. J., Shabanowitz, J., Hunt, D. F., and Syka, J. E. (2005) Electron transfer dissociation of peptide anions. J. Am. Soc. Mass Spectrom. 16, 880-882
22. Good, D. M., and Coon, J. J. (2006) Advancing proteomics with ion/ion chemistry. BioTechniques 40, 783-789
23. Syka, J. E., Coon, J. J., Schroeder, M. J., Shabanowitz, J., and Hunt, D. F. (2004) Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry. Proc. Natl. Acad. Sci. U. S. A. 101, 9528-9533
24. Good, D. M., Wirtala, M., McAlister, G. C., and Coon, J. J. (2007) Performance characteristics of electron transfer dissociation mass spectrometry. Mol. Cell. Proteomics 6, 1942-1951
25. McAlister, G. C., Phanstiel, D., Good, D. M., Berggren, W. T., and Coon, J. J. (2007) Implementation of electron transfer dissociation on a hybrid linear ion trap-orbitrap mass spectrometer. Anal. Chem. 79, 3525-3534
26. Zurbig, P., Renfrow, M. B., Schiffer, E., Novak, J., Walden, M., Wittke, S., Just, I., Pelzing, M., Neususs, C., Theodorescu, D., Root, K. E., Ross, M. M., and Mischak, H. (2006) Biomarker discovery by CE-MS enables sequence analysis via MS/MS with platform-independent separation. Electrophoresis 27, 2111-2125
27. Kolch, W., Mischak, H., and Pitt, A. R. (2005) The molecular make-up of a tumour: proteomics in cancer research. Clin. Sci. (Lond.) 108, 369-383
28. Verhave, J. C., Hillege, H. L., Burgerhof, J. G., Gansevoort, R. T., de Zeeuw, D., and de Jong, P. E.; PREVEND Study Group (2005) The association between atherosclerotic risk factors and renal function in the general population. Kidney Int. 67, 1967-1973
29. Pickering, J. G., Ford, C. M., and Chow, L. H. (1996) Evidence for rapid accumulation and persistently disordered architecture of fibrillar Collagen in human coronary restenosis lesions. Am. J. Cardiol. 78, 633-6537
30. Brew, K., Dinakarpandian, D., and Nagase, H. (2000) Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim. Biophys. Acta 1477, 267-283
31. Carmeliet, P., Moons, L., Lijnen, R., Baes, M., Lemaitre, V., Tipping, P., Drew, A., Eeckhout, Y., Shapiro, S., Lupu, F., and Collen, D. (1997) Urokinase-generated plasmin activates matrix metalloproteinases; during aneurysm formation. Nat. Genet. 17, 439-444
32. Gross, J., and Lapiere, C. M. (1962) Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc. Natl. Acad. Sci. U. S. A. 48, 1014-1022
33. Li, Y. Y., McTieman, C. F., and Feldman, A. M. (2000) Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling. Cardiovasc. Res. 46, 214-224
34. Stemlicht, M. D., and Werb, Z. (2001) How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 17, 463-516
35. Lee, R. T., and Libby, P. (1997) The unstable atheroma. Arterioscler. Thromb. Vasc. Biol. 17, 1859-1867
36. Kalela, A., Koivu, T. A., Sisto, T., Kanervisto, J., Hoyhtya, M., Sillanaukee, P., Lehtimaki, T., and Nikkari, S. T. (2002) Serum matrix metalloproteinase-9 concentration in angiographically assessed coronary artery disease. Scand. J Clin. Lab. Investig. 62, 337-342
37. Noji, Y., Kajinami, K., Kawashiri, M. A., Todo, Y., Horita, T., Nohara, A., Higashikata, T., Inazu, A., Koizumi, J., Takegoshi, T., and Mabuchi, H. (2001) Circulating matrix metalloproteinases and their inhibitors in premature coronary atherosclerosis. Clin. Chem. Lab. Med. 39, 380-384
38. Tayebjee, M. H., Tan, K. T., MacFadyen, R. J., and Lip, G. Y. (2005) Abnormal circulating levels of metalloprotease 9 and its tissue inhibitor 1 in angiographically proven peripheral arterial disease: relationship to disease severity. J. Intern. Med. 257, 110-116
39. Zouridakis, E., Avanzas, P., Arroyo-Espliguero, R., Fredericks, S., and Kaski, J. C. (2004) Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris. Circulation 110, 1747-1753
40. Blankenberg, S., Rupprecht, H. J., Poirier, O., Bickel, C., Smieja, M., Hafner, G., Meyer, J., Cambien, F., and Tiret, L. (2003) Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 107, 1579-1585
41. de Nooijer, R., Verkleij, C. J., der Thusen, J. H., Jukema, J. W., van der Wall, E. E., van Berkel, T. J., Baker, A. H., and Biessen, E. A. (2006) Lesional overexpression of matrix metalloproteinase-9 promotes intraplaque hemorrhage in advanced lesions but not at earlier stages of atherogenesis. Arterioscler. Thromb. Vasc. Biol. 26, 340-346
42. Fukuda, D., Shimada, K., Tanaka, A., Kusuyama, T., Yamashita, H., Ehara, S., Nakamura, Y., Kawarabayashi, T., Iida, H., Yoshiyama, M., and Yoshikawa, J. (2006) Comparison of levels of serum matrix metalloproteinase-9 in patients with acute myocardial infarction versus unstable angina pectoris versus stable angina pectoris. Am. J. Cardiol. 97, 175-180
43. Ingegno, M. D., Money, S. R., Thelmo, W., Greene, G. L., Davidian, M., Jaffe, B. M., and Pertschuk, L. P. (1988) Progesterone receptors in the human heart and great vessels. Lab. Investig. 59, 353-356
44. Duran, M. C., Martin-Ventura, J. L., Mas, S., Barderas, M. G., Darde, V. M., Jensen, O. N., Egido, J., and Vivanco, F. (2007) Characterization of the human atheroma plaque secretome by proteomic analysis. Methods Mol. Biol. 357, 141-150
45. Sung, H. J., Ryang, Y. S., Jang, S. W., Lee, C. W., Han, K. H., and Ko, J. (2006) Proteomic analysis of differential protein expression in atherosclerosis. Biomarkers 11, 279-290
46. Vaisar, T., Pennathur, S., Green, P. S., Gharib, S. A., Hoofnagle, A. N., Cheung, M. C., Byun, J., Vuletic, S., Kassim, S., Singh, P., Chea, H., Knopp, R. H., Brunzell, J., Geary, R., Chait, A., Zhao, X. Q., Elkon, K., Marcovina, S., Ridker, P., Oram, J. F., and Heinecke, J. W. (2007) Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. J. Clin. Investig. 117, 746-756
47. You, S. A., Archacki, S. R., Angheloiu, G., Moravec, C. S., Rao, S., Kinter, M., Topol, E. J., and Wang, Q. (2003) Proteomic approach to coronary atherosclerosis shows ferritin light chain as a significant marker: evidence consistent with iron hypothesis in atherosclerosis. Physiol. Genomics 13, 25-30
48. You, S. A., and Wang, Q. K. (2006) Proteomics with two-dimensional gel electrophoresis and mass spectrometry analysis in cardiovascular research. Methods Mol. Med. 129, 15-26
49. Berhane, B. T., Zong, C., Liem, D. A., Huang, A., Le, S., Edmondson, R. D., Jones, R. C., Qiao, X., Whitelegge, J. P., Ping, P., and Vondriska, T. M. (2005) Cardiovascular-related proteins identified in human plasma by the HUPO Plasma Proteome Project pilot phase. Proteomics 5, 3520-3530
50. Donahue, M. P., Rose, K., Hochstrasser, D., Vonderscher, J., Grass, P., Chibout, S. D., Nelson, C. L., Sinnaeve, P., Goldschmidt-Clermont, P. J., and Granger, C. B. (2006) Discovery of proteins related to coronary artery disease using inclustrial-scale proteomics analysis of pooled plasma. Am. Heart J. 152, 478-485
51. Abdul-Salam, V. B., Paul, G. A., Ali, J. O., Gibbs, S. R., Rahman, D., Taylor, G. W., Wilkins, M. R., and Edwards, R. J. (2006) Identification of plasma protein biomarkers associated with idiopathic pulmonary arterial hypertension. Proteomics 6, 2286-2294
52. Johnson, R. S., Martin, S. A., Biemann, K., Stults, J. T., and Watson, J. T. (1987) Novel fragmentation process of peptides by collision-induced decomposition in a tandem mass spectrometer: differentiation of leucine and isoleucine. Anal. Chem. 59, 2621-2625
53. Roepstorff, P., and Fohlman, J. (1984) Proposal for a common nomenclature for sequence ions in mass spectra of peptides. Biomed. Mass Spectrom. 11, 601